{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:02:39Z","timestamp":1790888559209,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.soncn.2023.151443","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T16:16:09Z","timestamp":1683735369000},"page":"151443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Symptom Clusters and Quality of Life in Patients With Breast Cancer Receiving Endocrine Therapy in China"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6591-9638","authenticated-orcid":false,"given":"Feng","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.soncn.2023.151443_bib0001","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000509362","article-title":"Endocrine therapy in early breast Cancer","volume":"15","author":"Krauss","year":"2020","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"10.1016\/j.soncn.2023.151443_bib0002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11764-020-00908-5","article-title":"How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support","volume":"15","author":"Berkowitz","year":"2021","journal-title":"J Cancer Surviv"},{"issue":"5","key":"10.1016\/j.soncn.2023.151443_bib0003","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1634\/theoncologist.2015-0349","article-title":"Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer","volume":"21","author":"Kadakia","year":"2016","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.soncn.2023.151443_bib0004","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1097\/NCC.0000000000000632","article-title":"Symptom map of endocrine therapy for breast cancer: a scoping review","volume":"42","author":"Zhu","year":"2019","journal-title":"Cancer Nurs"},{"issue":"2","key":"10.1016\/j.soncn.2023.151443_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-007-9548-1","article-title":"Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy","volume":"107","author":"Cella","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.soncn.2023.151443_bib0006","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JOP.18.00617","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update","volume":"15","author":"Burstein","year":"2019","journal-title":"J Oncol Pract"},{"issue":"8","key":"10.1016\/j.soncn.2023.151443_bib0007","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1200\/JCO.2015.64.3866","article-title":"Impact of adjuvant endocrine therapy on quality of life and symptoms: observational data over 12 months from the mind-body study","volume":"34","author":"Ganz","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.soncn.2023.151443_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jgo.2018.11.008","article-title":"Higher symptom burden is associated with lower function in women for taking adjuvant endocrine therapy for breast cancer","volume":"10","author":"Sitlinger","year":"2019","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"10.1016\/j.soncn.2023.151443_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230681","article-title":"Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer","volume":"15","author":"Martino","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.soncn.2023.151443_bib0010","first-page":"447","article-title":"Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors","volume":"23","author":"Olufade","year":"2015","journal-title":"Supportive Care Cancer"},{"issue":"11","key":"10.1016\/j.soncn.2023.151443_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187165","article-title":"Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study","volume":"12","author":"Laroche","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.soncn.2023.151443_bib0012","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jpainsymman.2019.10.002","article-title":"Symptom clusters in women with breast cancer during the first 18 months of adjuvant therapy","volume":"59","author":"Li","year":"2020","journal-title":"J Pain Symptom Manag"},{"issue":"08","key":"10.1016\/j.soncn.2023.151443_bib0013","first-page":"1201","article-title":"Symptom clusters and the effects on quality of life among breast cancer patients receiving aromatase in hibitors [in Chinese]","volume":"56","author":"Wen","year":"2021","journal-title":"Chin J Nurs"},{"issue":"1","key":"10.1016\/j.soncn.2023.151443_bib0014","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1188\/20.ONF.89-100","article-title":"Symptom clusters in breast cancer survivors: a latent class profile analysis","volume":"47","author":"Lee","year":"2020","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"10.1016\/j.soncn.2023.151443_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1037\/1082-989X.4.1.84","article-title":"Sample size in factor analysis","volume":"4","author":"MacCallum","year":"1999","journal-title":"Psychological Methods"},{"issue":"2","key":"10.1016\/j.soncn.2023.151443_bib0016","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006263818115","article-title":"Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B","volume":"55","author":"Fallowfield","year":"1999","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.soncn.2023.151443_bib0017","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.1997.15.3.974","article-title":"Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument","volume":"15","author":"Brady","year":"1997","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.soncn.2023.151443_bib0018","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/jpm5030229","article-title":"Comorbidities and quality of life among breast cancer survivors: a prospective study","volume":"5","author":"Fu","year":"2015","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.soncn.2023.151443_bib0019","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jpainsymman.2016.10.366","article-title":"Longitudinal examination of symptom profiles among breast cancer survivors","volume":"53","author":"Avis","year":"2017","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"10.1016\/j.soncn.2023.151443_bib0020","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1188\/06.ONF.E79-E89","article-title":"Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis","volume":"33","author":"Miaskowski","year":"2006","journal-title":"Oncol Nurs Forum"},{"issue":"4","key":"10.1016\/j.soncn.2023.151443_bib0021","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jpainsymman.2013.05.012","article-title":"Symptom burden clusters: a challenge for targeted symptom management. A longitudinal study examining symptom burden clusters in breast cancer","volume":"47","author":"Kenne Sarenmalm","year":"2014","journal-title":"J Pain Symptom Manage"},{"issue":"21","key":"10.1016\/j.soncn.2023.151443_bib0022","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","article-title":"Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial","volume":"22","author":"Fallowfield","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.soncn.2023.151443_bib0023","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","article-title":"Quality of life of postmenopausal women in the ATAC (\"Arimidex\", Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for early breast cancer","volume":"100","author":"Cella","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"29","key":"10.1016\/j.soncn.2023.151443_bib0024","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.3748\/wjg.v25.i29.3838","article-title":"Healthy axis: towards an integrated view of the gut-brain health","volume":"25","author":"Boem","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"6571","key":"10.1016\/j.soncn.2023.151443_bib0025","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.abi6087","article-title":"Signaling inflammation across the gut-brain axis","volume":"374","author":"Agirman","year":"2021","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.soncn.2023.151443_bib0026","first-page":"e12919","article-title":"Symptom clusters and quality of life in breast cancer survivors after cancer treatment in a tertiary hospital in Korea","volume":"27","author":"Nho","year":"2018","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"1","key":"10.1016\/j.soncn.2023.151443_bib0027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-011-1943-y","volume":"133","author":"Takei","year":"2012","journal-title":"Breast Cancer Res Tr"},{"issue":"4","key":"10.1016\/j.soncn.2023.151443_bib0028","first-page":"937","article-title":"Associations between adjuvant endocrine therapy and onset of physical and emotional concerns among breast cancer survivors","volume":"22","author":"van Londen","year":"2014","journal-title":"Supportive Care Cancer"},{"issue":"1","key":"10.1016\/j.soncn.2023.151443_bib0029","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/NCC.0b013e31824a7e18","article-title":"Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers","volume":"36","author":"Boonstra","year":"2013","journal-title":"Cancer Nurs"},{"issue":"5","key":"10.1016\/j.soncn.2023.151443_bib0030","first-page":"1673","article-title":"Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis","volume":"25","author":"Beckwee","year":"2017","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.soncn.2023.151443_bib0031","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/annonc\/mdt037","article-title":"Aromatase inhibitor-induced arthralgia: a review","volume":"24","author":"Niravath","year":"2013","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.soncn.2023.151443_bib0032","article-title":"Understanding pain related to adjuvant endocrine therapy after breast cancer: a qualitative report","volume":"31","author":"Walsh","year":"2022","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.soncn.2023.151443_bib0033","doi-asserted-by":"crossref","DOI":"10.1186\/s40064-016-2136-2","article-title":"Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors","volume":"5","author":"Ates","year":"2016","journal-title":"Springerplus"},{"issue":"2","key":"10.1016\/j.soncn.2023.151443_bib0034","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000509651","article-title":"Aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer: profiles of psychological symptoms and quality of life in different patient clusters","volume":"99","author":"Borreani","year":"2021","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.soncn.2023.151443_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S1478951512000636","article-title":"Aromatase inhibitors and mood disturbances","volume":"10","author":"Rocha-Cadman","year":"2012","journal-title":"Palliat Support Care"},{"issue":"8","key":"10.1016\/j.soncn.2023.151443_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000081","article-title":"Aromatase inhibitors: role in postmenopausal breast cancer","volume":"353","author":"Kharb","year":"2020","journal-title":"Arch Pharm (Weinheim)"},{"issue":"2","key":"10.1016\/j.soncn.2023.151443_bib0037","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5306\/wjco.v13.i2.71","article-title":"Management of genitourinary syndrome of menopause in breast cancer survivors: an update","volume":"13","author":"Lubian Lopez","year":"2022","journal-title":"World J Clin Oncol"},{"issue":"4","key":"10.1016\/j.soncn.2023.151443_bib0038","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000510079","article-title":"Sexual dysfunction in postmenopausal women with breast cancer on adjuvant aromatase inhibitor therapy","volume":"16","author":"Lubian Lopez","year":"2021","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"10.1016\/j.soncn.2023.151443_bib0039","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-013-2659-y","article-title":"The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study","volume":"141","author":"Frechette","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.soncn.2023.151443_bib0040","first-page":"3633","article-title":"Sexual quality of life assessment in young women with breast cancer during adjuvant endocrine therapy and patient-reported supportive measures","volume":"30","author":"Bobrie","year":"2022","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.soncn.2023.151443_bib0041","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1634\/theoncologist.2015-0007","article-title":"Symptoms and symptom attribution among women on endocrine therapy for breast cancer","volume":"20","author":"Rosenberg","year":"2015","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.soncn.2023.151443_bib0042","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.critrevonc.2005.04.009","article-title":"Hot flushes in breast cancer patients","volume":"57","author":"Mom","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.soncn.2023.151443_bib0043","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(11)70364-3","article-title":"Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial","volume":"13","author":"Mann","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208123000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208123000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:42:19Z","timestamp":1760082139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208123000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0749208123000803"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2023.151443","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptom Clusters and Quality of Life in Patients With Breast Cancer Receiving Endocrine Therapy in China","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2023.151443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151443"}}